Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809-Reference-Cited by-同舟云学术

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Published:2011-06 Issue:6 Volume:22 Page:1382-1391
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ohmachi K.,Tobinai K.,Kobayashi Y.,Itoh K.,Nakata M.,Shibata T.,Morishima Y.,Ogura M.,Suzuki T.,Ueda R.,Aikawa K.,Nakamura S.,Fukuda H.,Shimoyama M.,Hotta T.

Funder

Cancer Research

Second Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/6/1382/581465/mdq619.pdf

Reference30 articles.

1. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma;McKelvey;Cancer,1976

2. Treatment of non-Hodgkin’s lymphoma;Armitage;N Engl J Med,1993

3. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin’s lymphoma;Gordon;N Engl J Med,1992

4. Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin’s lymphoma. The Australian and New Zealand Lymphoma Group;Cooper;J Clin Oncol,1994

5. CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin’s lymphomas: long-term results of a multicenter randomized trial. (PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hematology);Montserrat;Eur J Haematol,1996

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma;Annals of Hematology;2024-09-04

2. A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma;Journal of Clinical and Experimental Hematopathology;2022

3. RCHOP-14 therapy versus RCHOP-21 therapy for people with aggressive or advanced-stage indolent B-cell non-Hodgkins lymphoma: a systematic review and meta-analysis;Translational Cancer Research;2021-05

4. Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy;Supportive Care in Cancer;2021-02-24

5. Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A;Journal of Clinical and Experimental Hematopathology;2021